Related Experiment Video
Updated: Aug 4, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
The impact of COVID-19 on heart failure admissions in Suriname-A call for action
S Sairras1, S Baldew2, C Goberdhan2
1Scientific Research Center Suriname (SRCS), Academic Hospital Paramaribo (AZP), Suriname.
Insights
Heart failure (HF) admissions decreased during the COVID-19 pandemic, but readmissions rose significantly. Implementing telehealth strategies in Suriname can improve healthcare access and mitigate adverse effects for HF patients.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- The COVID-19 pandemic prompted global healthcare reorganizations, impacting services for chronic conditions like heart failure (HF).
- Limited data exists on the pandemic's effect on HF hospitalizations in Low and Middle Income Countries (LMICs), such as Suriname.
Purpose of the Study:
- To assess changes in heart failure hospitalizations in Suriname before and during the COVID-19 pandemic.
- To identify the need for improved healthcare access through telehealth strategies in LMICs.
Main Methods:
- Retrospective analysis of clinical and demographic data for patients hospitalized with HF at Academic Hospital Paramaribo.
- Comparison of data from February-December 2019 (pre-pandemic) and February-December 2020 (during the pandemic).
- Statistical analysis using t-tests for continuous variables and two-sample proportion tests for categorical variables.
Main Results:
- A 9.1% decrease in overall HF admissions was observed during the pandemic.
- Significantly fewer patients were hospitalized (18.3% decrease), but readmissions increased significantly (90-day: 19.6% vs 13.2%; 365-day: 31.9% vs 16.7%).
- Pandemic admissions showed significantly higher rates of comorbidities: hypertension (46.2%), diabetes (31.9%), anemia (12.8%), and atrial fibrillation (22.7%).
Conclusions:
- The COVID-19 pandemic led to reduced HF admissions but increased readmissions in Suriname.
- The inactivity of the HF clinic due to consultation restrictions highlights the need for remote monitoring solutions.
- Developing and implementing telehealth strategies, addressing digital literacy and legislation, is crucial for improving HF care in LMICs.
Introduction:
During the height of the COVID-19 pandemic, there was a worldwide reorganization of healthcare systems focusing on limiting the spread of the virus. The impact of these measures on heart failure (HF) admissions is scarcely reported in Low and Middle Income Countries (LMICs) including Suriname. We therefore assessed HF hospitalizations before and during the pandemic and call for action to improve healthcare access in Suriname through the development and implementation of telehealth strategies.
Methods:
Retrospectively collected clinical (# hospitalizations per patient, in hospital mortality, comorbidities) and demographic (sex, age, ethnicity) data of people hospitalized with a primary or secondary HF discharge ICD10 code in the Academic Hospital Paramaribo (AZP) from February to December 2019 (pre-pandemic) and February to December 2020 (during the pandemic) were used for analysis. Data are presented as frequencies with corresponding percentages. T-tests were used to analyze continuous variables and the two-sample test for proportions for categorical variables.
Results:
There was an overall slight decrease of 9.1% HF admissions (N pre-pandemic:417 vs N during the pandemic: 383). Significantly less patients (18.3%, p-value<0.00) were hospitalized during the pandemic (N: 249 (65.0%)) compared to pre-pandemic (N: 348 (83.3%)), while readmissions increased statistically significantly for both readmissions within 90 days (75 (19.6%) vs 55 (13.2%), p-value = 0.01) and readmissions within 365 days (122 (31.9%) vs 70 (16.7%), p-value = 0.00) in 2020 compared to 2019. Patients admitted during the pandemic also had significantly more of the following comorbidities: hypertension (46.2% vs 30.6%, p-value = 0.00), diabetes (31.9% vs 24.9%, p-value = 0.03) anemia (12.8% vs 3.1%, p-value = 0.00), and atrial fibrillation (22.7% vs 15.1%, p-value = 0.00).
Conclusion:
HF admissions were reduced during the pandemic while HF readmissions increased compared to the pre-pandemic period. Due to in-person consultation restrictions, the HF clinic was inactive during the pandemic period. Distance monitoring of HF patients via telehealth tools could help in reducing these adverse effects. This call for action identifies key elements (digital and health literacy, telehealth legislation, integration of telehealth tools within the current healthcare sector) needed for the successful development and implementation of these tools in LMICs.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure Drugs: Inotropic Agents

